/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Evolus, Inc. Share Price Today: Live Updates & Key Insights

Evolus, Inc. share price today is $5.95, up -0.17%. The stock opened at $6.01 against the previous close of $5.99, with an intraday high of $6.04 and low of $5.85.

Evolus, Inc. Share Price Chart

style
pb-0

Evolus, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Evolus, Inc. Share Price Performance

$5.95 -0.0017(-0.17%) EOLS at 27 Jul 2026 02:52 PM Drug Manufacturers - Specialty & Generic
Lowest Today 5.85
Highest Today 6.04
Today’s Open 6.01
Prev. Close 5.99
52 Week High 9.58
52 Week Low 3.86
Day’s Range: Low 5.85 High 6.04
52-Week Range: Low 3.86 High 9.58
1 day return -
1 Week return +7.93
1 month return -16.05
3 month return +14.43
6 month return +24.42
1 year return -35.5
3 year return -23.22
5 year return -43.8
10 year return -

Evolus, Inc. Institutional Holdings

Nantahala Capital Management, LLC 9.68

BlackRock Inc 6.51

Vanguard Group Inc 5.07

BRAIDWELL LP 4.72

Frazier Life Sciences Management, L.P. 3.99

Vanguard Capital Management, LLC 3.75

Soleus Capital Management, L.P. 3.41

Stonepine Capital Management Llc 2.67

iShares Russell 2000 ETF 2.35

Vanguard Total Stock Mkt Idx Inv 2.35

Millennium Management LLC 2.22

Armistice Capital, LLC 2.12

Geode Capital Management, LLC 2.10

State Street Corp 2.01

Perceptive Advisors LLC 1.95

Rice Hall James & Associates, LLC 1.91

Pinnacle Associates Inc 1.76

The Goldman Sachs Group Inc 1.65

Assenagon Asset Management SA 1.38

Vanguard Institutional Extnd Mkt Idx Tr 1.17

UBS Group AG 1.14

Citadel Advisors Llc 1.06

Soviero Asset Management, LP 1.03

iShares Russell 2000 Growth ETF 0.84

Fidelity Small Cap Index 0.84

Xtrackers MSCI World Swap ETF 1C 0.60

State St Russell Sm/Mid Cp® Indx SL Cl I 0.56

Russell 2000 Equity Index Fund B 0.52

Russell 2000 Index Non-Lendable Fund 0.52

Vanguard Russell 2000 ETF 0.52

Fidelity Extended Market Index 0.51

State Street® SPDR® S&P® PhrmctlsETF 0.49

Schwab US Small-Cap ETF™ 0.47

State St Russell Sm Cap® Idx SL Cl I 0.31

iShares Micro-Cap ETF 0.30

iShares US Pharmaceuticals ETF 0.26

Extended Equity Market Fund B 0.26

Extended Equity Market Fund E 0.26

Blackrock Extended Mkt Fund CF 0.25

BlackRock Extended Equity Market Fund K 0.22

Evolus, Inc. Market Status

Strong Buy: 4

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Evolus, Inc. Fundamentals

Market Cap 394.47 M

PB Ratio 53.7058

PE Ratio 0.0

Enterprise Value 509.91 M

Total Assets 225.87 M

Volume 697012

Evolus, Inc. Company Financials

Annual Revenue FY23:184732000 184.7M, FY22:148616000 148.6M, FY21:99673000 99.7M, FY20:56540000 56.5M, FY19:34925000 34.9M

Annual Profit FY23:129073000 129.1M, FY22:92729000 92.7M, FY21:56139000 56.1M, FY20:38241000 38.2M, FY19:26911000 26.9M

Annual Net worth FY23:-63018000 -63.0M, FY22:-74412000 -74.4M, FY21:-46810000 -46.8M, FY20:-163013000 -163.0M, FY19:-90034000 -90.0M

Quarterly Revenue Q1/2026:73137000 73.1M, Q3/2025:68967000 69.0M, Q2/2025:69387000 69.4M, Q1/2025:68522000 68.5M, Q3/2024:61085000 61.1M

Quarterly Profit Q1/2026:47359000 47.4M, Q3/2025:45841000 45.8M, Q2/2025:45320000 45.3M, Q1/2025:46655000 46.7M, Q3/2024:42862000 42.9M

Quarterly Net worth Q1/2026:-10674000 -10.7M, Q3/2025:-15737000 -15.7M, Q2/2025:-17142000 -17.1M, Q1/2025:-18892000 -18.9M, Q3/2024:-19170000 -19.2M

About Evolus, Inc. & investment objective

Company Information Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Organisation Drug Manufacturers - Specialty & Generic

Employees 350

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. David Moatazedi

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Evolus, Inc. FAQs

What is the share price of Evolus, Inc. today?

The current share price of Evolus, Inc. is $5.95.

Can I buy Evolus, Inc. shares in India?

Yes, Indian investors can buy Evolus, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Evolus, Inc. shares in India?

You can easily invest in Evolus, Inc. shares from India by:

Can I buy fractional shares of Evolus, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Evolus, Inc.?

Evolus, Inc. has a market cap of $394.47 M.

In which sector does Evolus, Inc. belong?

Evolus, Inc. operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Evolus, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Evolus, Inc.?

The PE ratio of Evolus, Inc. is N/A and the PB ratio is 53.71.